Skip to main content
. 2017 Jul 10;74(7):839–846. doi: 10.1001/jamaneurol.2017.0603

Table 3. Causes of Death for Patients With Any Synucleinopathy, and for PD, Compared With Referent Participants.

Primary Cause of Death No. (%)
Patients
(n = 311)a
Referent Participants
(n = 216)a
Synucleinopathies
Neurodegenerative disease 98 (31.5) 25 (11.6)
Cardiovascular events 49 (15.8) 55 (25.5)
Respiratory failure/pneumonia 48 (15.4) 32 (14.8)
Others 29 (9.3) 19 (8.8)
Aspiration 25 (8.1) 7 (3.2)
Cancers 22 (7.1) 39 (18.1)
Sepsis 17 (5.5) 9 (4.2)
Stroke/hemorrhages 11 (3.5) 16 (7.4)
Traumas (including falls) 7 (2.3) 8 (3.7)
Renal failure 5 (1.6) 6 (2.8)
Patients
(n = 172)
Referent Participants
(n = 130)
Parkinson Disease
Neurodegenerative disease 44 (25.6) 10 (7.7)
Cardiovascular events 28 (16.3) 34 (26.2)
Respiratory failure/pneumonia 23 (13.4) 17 (13.1)
Cancers 20 (11.6) 29 (22.3)
Others 19 (11.1) 11 (8.5)
Aspiration 15 (8.7) 4 (3.1)
Stroke/hemorrhages 9 (5.2) 11 (8.5)
Traumas (including falls) 5 (2.9) 6 (4.6)
Sepsis 5 (2.9) 5 (3.8)
Renal failure 4 (2.3) 3 (2.3)

Abbreviation: PD, Parkinson disease.

a

Death certificates were not available for 5 patients and 4 referent participants. These persons are not included in this table.